This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

1 Mar 2011

Two European Cell Therapy Companies Merge

This consolidation between the two leading European stem cell companies represents an important step in the field of regenerative medicine and cell therapy.

Belgium's TiGenix and Spain's Cellerix have decided to merge their operations. The new biotech group will have $33 million on hand to support its pipeline.


Cellerix has a clinical stage pipeline of cell-based products for inflammatory and autoimmune indications and recently completed a successful Phase IIa study in complex perianal fistula in Crohn's patients. Cellerix has received authorization to start a Phase I/II study in rheumatoid arthritis. TiGenix is exploring the use of regenerative medicine to develop local treatments for

Related News